With record speed, little more than a year after Covid-19 first hit the headlines, the global drug industry has developed a growing number of vaccines that prevent severe disease and slow the spread of the virus. Yet the deployment of these vaccines has fallen short of hopes and expectations. Time is of the essence, with new virus variants looming and the summer offering a preciously short window to push the virus out of circulation before its reproduction rate rises again in the fall.
